{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:09:03Z","timestamp":1787972943341,"version":"build-2784847793"},"reference-count":70,"publisher":"The Endocrine Society","issue":"6","funder":[{"name":"AstraZeneca Pharmaceuticals LP"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1210\/jc.2018-01741","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T19:08:34Z","timestamp":1546024114000},"page":"1953-1966","source":"Crossref","is-referenced-by-count":45,"title":["Influence of Sodium Glucose Cotransporter 2 Inhibition on Physiological Adaptation to Endurance Exercise Training"],"prefix":"10.1210","volume":"104","author":[{"given":"Alissa A","family":"Newman","sequence":"first","affiliation":[{"name":"Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan C","family":"Grimm","sequence":"additional","affiliation":[{"name":"Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie R","family":"Wilburn","sequence":"additional","affiliation":[{"name":"Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden M","family":"Schoenberg","sequence":"additional","affiliation":[{"name":"Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Raj J","family":"Trikha","sequence":"additional","affiliation":[{"name":"Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J","family":"Luckasen","sequence":"additional","affiliation":[{"name":"Medical Center of the Rockies Foundation, University of Colorado Health, Loveland, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie M","family":"Biela","sequence":"additional","affiliation":[{"name":"Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L","family":"Melby","sequence":"additional","affiliation":[{"name":"Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7706-0912","authenticated-orcid":false,"given":"Christopher","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,12,28]]},"reference":[{"issue":"6","key":"2019041614024975400_B1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"2019041614024975400_B2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"2019041614024975400_B3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"issue":"12","key":"2019041614024975400_B4","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"issue":"7","key":"2019041614024975400_B5","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2337\/dc10-2207","article-title":"Metformin and exercise in type 2 diabetes: examining treatment modality interactions","volume":"34","author":"Boul\u00e9","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"2019041614024975400_B6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1139\/H07-144","article-title":"Impact of metformin on peak aerobic capacity","volume":"33","author":"Braun","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"issue":"3","key":"2019041614024975400_B7","doi-asserted-by":"crossref","first-page":"E300","DOI":"10.1152\/ajpendo.00427.2013","article-title":"Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats","volume":"306","author":"Linden","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2019041614024975400_B8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/oby.20235","article-title":"Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults","volume":"21","author":"Malin","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"2019041614024975400_B9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcjd.2015.08.015","article-title":"The effect of exercise with or without metformin on glucose profiles in type 2 diabetes: a pilot study","volume":"40","author":"Myette-C\u00f4t\u00e9","year":"2016","journal-title":"Can J Diabetes"},{"issue":"4","key":"2019041614024975400_B10","doi-asserted-by":"crossref","first-page":"E815","DOI":"10.1152\/ajpendo.00517.2009","article-title":"Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individuals","volume":"298","author":"Sharoff","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"2019041614024975400_B11","doi-asserted-by":"crossref","first-page":"e0168065","DOI":"10.1371\/journal.pone.0168065","article-title":"The impact of exercise on statin-associated skeletal muscle myopathy","volume":"11","author":"Chung","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"2019041614024975400_B12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jacc.2013.02.074","article-title":"Simvastatin impairs exercise training adaptations","volume":"62","author":"Mikus","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2019041614024975400_B13","doi-asserted-by":"crossref","first-page":"e0179534","DOI":"10.1371\/journal.pone.0179534","article-title":"Statins are related to impaired exercise capacity in males but not females","volume":"12","author":"Bahls","year":"2017","journal-title":"PLoS One"},{"issue":"13","key":"2019041614024975400_B14","doi-asserted-by":"crossref","first-page":"e13754","DOI":"10.14814\/phy2.13754","article-title":"Glucagon-like peptide-1 receptor antagonism impairs basal exercise capacity and vascular adaptation to aerobic exercise training in rats","volume":"6","author":"Scalzo","year":"2018","journal-title":"Physiol Rep"},{"issue":"7","key":"2019041614024975400_B15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/dom.12900","article-title":"Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: a randomized double-blind placebo-controlled clinical trial","volume":"19","author":"J\u00f8rgensen","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2019041614024975400_B16","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jbmr.24","article-title":"Timing of ibuprofen use and bone mineral density adaptations to exercise training","volume":"25","author":"Kohrt","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2019041614024975400_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bonr.2014.10.003","article-title":"Timing of ibuprofen use and musculoskeletal adaptations to exercise training in older adults","volume":"1","author":"Jankowski","year":"2015","journal-title":"Bone Rep"},{"issue":"4","key":"2019041614024975400_B18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1249\/MSS.0000000000001172","article-title":"Effects of ibuprofen and resistance training on bone and muscle: a randomized controlled trial in older women","volume":"49","author":"Duff","year":"2017","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"2019041614024975400_B19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1152\/japplphysiol.00277.2018","article-title":"Differential effects of vitamin C or protandim on skeletal muscle adaptation to exercise","volume":"125","author":"Bruns","year":"2018","journal-title":"J Appl Physiol (1985)"},{"issue":"8","key":"2019041614024975400_B20","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1113\/jphysiol.2013.267419","article-title":"Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial","volume":"592","author":"Paulsen","year":"2014","journal-title":"J Physiol"},{"issue":"9","key":"2019041614024975400_B21","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.2337\/dc14-1395","article-title":"Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors\u2019 expert forum","volume":"37","author":"Cefalu","year":"2014","journal-title":"Diabetes Care"},{"issue":"16","key":"2019041614024975400_B22","doi-asserted-by":"crossref","first-page":"12032","DOI":"10.1016\/S0021-9258(17)32677-7","article-title":"The high affinity Na+\/glucose cotransporter. Re-evaluation of function and distribution of expression","volume":"269","author":"Lee","year":"1994","journal-title":"J Biol Chem"},{"issue":"5","key":"2019041614024975400_B23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2146\/ajhp140168","article-title":"Dapagliflozin: a new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes","volume":"72","author":"Vivian","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"2019041614024975400_B24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clinthera.2013.11.002","article-title":"Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study","volume":"36","author":"Ji","year":"2014","journal-title":"Clin Ther"},{"issue":"23","key":"2019041614024975400_B25","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1016\/j.jacc.2018.03.009","article-title":"Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 Study","volume":"71","author":"Kosiborod","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2019041614024975400_B26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12933-018-0708-x","article-title":"SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice","volume":"17","author":"Lee","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2019041614024975400_B27","article-title":"Switching dipeptidyl peptidase-4 inhibitors to tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2 improves arterial stiffness evaluated by cardio-ankle vascular index in patients with type 2 diabetes: a pilot study [published online ahead of print 15 May 2018]","author":"Bekki","journal-title":"Curr Vasc Pharmacol"},{"issue":"5","key":"2019041614024975400_B28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"2019041614024975400_B29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-016-0489-z","article-title":"Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes","volume":"16","author":"Habibi","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2019041614024975400_B30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12933-018-0775-z","article-title":"Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure","volume":"17","author":"Soga","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2019041614024975400_B31","doi-asserted-by":"crossref","first-page":"e90696","DOI":"10.1371\/journal.pone.0090696","article-title":"Regulators of human white adipose browning: evidence for sympathetic control and sexual dimorphic responses to sprint interval training","volume":"9","author":"Scalzo","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2019041614024975400_B32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1249\/MSS.0b013e3181bcab6c","article-title":"Epigallocatechin-3-gallate increases maximal oxygen uptake in adult humans","volume":"42","author":"Richards","year":"2010","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"2019041614024975400_B33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med Sci Sports Exerc"},{"key":"2019041614024975400_B34","doi-asserted-by":"crossref","first-page":"6436783","DOI":"10.1155\/2017\/6436783","article-title":"Concurrent beet juice and carbohydrate ingestion: influence on glucose tolerance in obese and nonobese adults","volume":"2017","author":"Beals","year":"2017","journal-title":"J Nutr Metab"},{"issue":"9","key":"2019041614024975400_B35","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"2","key":"2019041614024975400_B36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/jc.2014-2299","article-title":"Fasting and OGTT-derived measures of insulin resistance as compared with the euglycemic-hyperinsulinemic clamp in nondiabetic Finnish offspring of type 2 diabetic individuals","volume":"100","author":"Lorenzo","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041614024975400_B37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1440-1681.12761","article-title":"Ergogenic properties of metformin in simulated high altitude","volume":"44","author":"Scalzo","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"9786","key":"2019041614024975400_B38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(11)60442-X","article-title":"Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial","volume":"378","author":"Andrews","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"2019041614024975400_B39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2840-7-13","article-title":"Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice","volume":"7","author":"Kivel\u00e4","year":"2008","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2019041614024975400_B40","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1210\/jc.2010-2532","article-title":"Impaired muscle AMPK activation in the metabolic syndrome may attenuate improved insulin action after exercise training","volume":"96","author":"Layne","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 23","key":"2019041614024975400_B41","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1113\/jphysiol.2009.180174","article-title":"Chronic high fat feeding attenuates load-induced hypertrophy in mice","volume":"587","author":"Sitnick","year":"2009","journal-title":"J Physiol"},{"issue":"4","key":"2019041614024975400_B42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/JES.0b013e31822673f0","article-title":"Pigment epithelium-derived factor: a not so sympathetic regulator of insulin resistance","volume":"39","author":"Bell","year":"2011","journal-title":"Exerc Sport Sci Rev"},{"issue":"Pt 1","key":"2019041614024975400_B43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1113\/jphysiol.2009.184747","article-title":"Muscle-to-fat interaction: a two-way street","volume":"588","author":"Pedersen","year":"2010","journal-title":"J Physiol"},{"issue":"1","key":"2019041614024975400_B44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/17461391.2014.959564","article-title":"Rethinking fat as a fuel for endurance exercise","volume":"15","author":"Volek","year":"2015","journal-title":"Eur J Sport Sci"},{"issue":"5","key":"2019041614024975400_B45","doi-asserted-by":"crossref","first-page":"e2886","DOI":"10.1002\/dmrr.2886","article-title":"Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: basic mechanisms and therapeutic perspectives","volume":"33","author":"Qiu","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"2019041614024975400_B46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jacbts.2018.08.002","article-title":"Refueling the failing heart: a case for sodium-glucose cotransporter 2 inhibition in cardiac energy homeostasis","volume":"3","author":"Crawford","year":"2018","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"2019041614024975400_B47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","article-title":"Empagliflozin increases cardiac energy production in diabetes: novel translational insights into the heart failure benefits of SGLT2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"2019041614024975400_B48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion","volume":"21","author":"Bonner","year":"2015","journal-title":"Nat Med"},{"issue":"3","key":"2019041614024975400_B49","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00005768-200203000-00011","article-title":"Effect of short-term fat adaptation on high-intensity training","volume":"34","author":"Stepto","year":"2002","journal-title":"Med Sci Sports Exerc"},{"issue":"Pt 3","key":"2019041614024975400_B50","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1469-7793.1999.0919s.x","article-title":"The effects of exercise and diet manipulation on the capacity to perform prolonged exercise in the heat and in the cold in trained humans","volume":"517","author":"Pitsiladis","year":"1999","journal-title":"J Physiol"},{"issue":"1","key":"2019041614024975400_B51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1249\/01.MSS.0000106183.23941.54","article-title":"Gender differences in perceived exertion during fatiguing knee extensions","volume":"36","author":"Pincivero","year":"2004","journal-title":"Med Sci Sports Exerc"},{"issue":"8","key":"2019041614024975400_B52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1055\/s-2004-830440","article-title":"Sex-related differences in ratings of perceived exertion and estimated time limit","volume":"26","author":"Garcin","year":"2005","journal-title":"Int J Sports Med"},{"issue":"3","key":"2019041614024975400_B53","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/jdi.12726","article-title":"Changes in heart rate in patients with type\u00a02 diabetes mellitus after treatment with luseogliflozin: subanalysis of placebo-controlled, double-blind clinical trials","volume":"9","author":"Sano","year":"2018","journal-title":"J Diabetes Investig"},{"issue":"3","key":"2019041614024975400_B54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13300-011-0003-2","article-title":"Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT\/QTc study","volume":"2","author":"Carlson","year":"2011","journal-title":"Diabetes Ther"},{"issue":"1","key":"2019041614024975400_B55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1475-2840-12-70","article-title":"The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study","volume":"12","author":"Ring","year":"2013","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2019041614024975400_B56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-2840-13-28","article-title":"The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus","volume":"13","author":"Cherney","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2019041614024975400_B57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","article-title":"Possible adverse effects of SGLT2 inhibitors on bone","volume":"3","author":"Taylor","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2019041614024975400_B58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/00325481.2017.1256747","article-title":"Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus","volume":"129","author":"Blevins","year":"2017","journal-title":"Postgrad Med"},{"issue":"4","key":"2019041614024975400_B59","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/dom.13176","article-title":"Initiation of dapagliflozin and treatment-emergent fractures","volume":"20","author":"Toulis","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2019041614024975400_B60","doi-asserted-by":"crossref","first-page":"e2903","DOI":"10.1002\/dmrr.2903","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis","volume":"33","author":"Ruanpeng","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"2019041614024975400_B61","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/clpt.2008.251","article-title":"Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects","volume":"85","author":"Komoroski","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"2019041614024975400_B62","first-page":"1211","article-title":"Pharmacokinetic and pharmacodynamic properties of single- and multiple-dose of dapagliflozin, a selective inhibitor of SGLT2, in healthy Chinese subjects","volume":"35","author":"Yang","year":"2013","journal-title":"lin Ther"},{"issue":"9","key":"2019041614024975400_B63","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/nu10091140","article-title":"Acute and chronic effects of exercise on appetite, energy intake, and appetite-related hormones: the modulating effect of adiposity, sex, and habitual physical activity","volume":"10","author":"Dorling","year":"2018","journal-title":"Nutrients"},{"issue":"14","key":"2019041614024975400_B64","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1113\/jphysiol.2012.230185","article-title":"Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects","volume":"590","author":"Larsen","year":"2012","journal-title":"J Physiol"},{"issue":"2","key":"2019041614024975400_B65","first-page":"84","article-title":"The relationship between skeletal muscle mitochondrial citrate synthase activity and whole body oxygen uptake adaptations in response to exercise training","volume":"6","author":"Vigels\u00f8","year":"2014","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"Pt 15","key":"2019041614024975400_B66","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1113\/jphysiol.2010.189886","article-title":"Short-term sprint interval training increases insulin sensitivity in healthy adults but does not affect the thermogenic response to beta-adrenergic stimulation","volume":"588","author":"Richards","year":"2010","journal-title":"J Physiol"},{"issue":"1","key":"2019041614024975400_B67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/sms.12875","article-title":"Increased insulin-stimulated glucose uptake in both leg and arm muscles after sprint interval and moderate-intensity training in subjects with type 2 diabetes or prediabetes","volume":"28","author":"Sj\u00f6ros","year":"2018","journal-title":"Scand J Med Sci Sports"},{"issue":"6","key":"2019041614024975400_B68","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/17461391.2017.1310933","article-title":"Exercise but not metformin improves health-related quality of life and mood states in older adults with type 2 diabetes","volume":"17","author":"Baptista","year":"2017","journal-title":"Eur J Sport Sci"},{"issue":"8","key":"2019041614024975400_B69","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s11136-017-1543-3","article-title":"Effects of long-term multicomponent exercise on health-related quality of life in older adults with type 2 diabetes: evidence from a cohort study","volume":"26","author":"Baptista","year":"2017","journal-title":"Qual Life Res"},{"issue":"8","key":"2019041614024975400_B70","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.3346\/jkms.2018.33.e60","article-title":"Diabetes, frequency of exercise, and mortality over 12 years: analysis of the National Health Insurance Service\u2013Health Screening (NHIS-HEALS) database","volume":"33","author":"Shin","year":"2018","journal-title":"J Korean Med Sci"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/6\/1953\/28462663\/jc.2018-01741.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T06:41:26Z","timestamp":1662705686000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/6\/1953\/5262416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,28]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,12,28]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01741","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2018,12,28]]}}}